Trial Profile
A Prospective, Single-center, Open-label, Pilot Study to Investigate the Effect of Switching to Certican in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Mycophenolate mofetil; Mycophenolate sodium; Prednisone; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms CONCERVIC
- 02 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 Nov 2011 New trial record